The Decentralized Trials & Research Alliance enables collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life sciences and healthcare through education and research.
Our vision is to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods.
DTRA Members are driving the future of decentralized research through collaborative work on Initiative Teams to develop strategic solutions in 4 Priority areas.
DTRA Organizational Members share reasons for joining our unique Alliance focused on accelerating the adoption of decentralized clinical research.
With more than 100 Organizational Members, DTRA is driving the future of decentralized clinical research.
DTRA Organizational Membership
Decentralized Trials & Research Alliance Members represent the diverse ecosystem required to support the adoption of decentralized research methods.
Organizational Members include pharmaceutical and biotechnology companies, regulatory authorities, patient/advocacy organizations, clinical research organizations, technology companies, specialized service providers, investigator site networks, consulting organizations, and other stakeholders.
If you are interested in learning more about becoming an Organizational Member of DTRA, we invite you to explore the many benefits of membership today.
Collaborate and network among the leaders in the field of decentralized clinical research as a proponent of our shared mission to accelerate the adoption of patient-focused, decentralized clinical trials and research through education and research.
We welcome you to apply for an Individual Membership if you are a member of the DCT Community who is looking to join us in our mission of acceleration of adoption of patient-focused, decentralized clinical trials and research.
